ORGO

Organogenesis Holdings Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↓ 1/10
  • Value↓ 4/10
Organogenesis Holdings sales and earnings growth
ORGO Growth
Low
  • Revenue Y/Y↑ 10.61%
  • EPS Y/Y↑ 11.76%
  • FCF Y/Y↑ 343.99%
Organogenesis Holdings gross and profit margin trends
ORGO Profitability
Neutral
  • Gross margin ↑ 72.90%
  • EPS margin↓ -3.60%
  • ROIC 5Y↓ 0.64%
Organogenesis Holdings net debt vs free cash flow
ORGO Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 2.2

Organogenesis Holdings stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks